| 1/10 | US=84 / Biol/Mol Todorovic V, Rifkin DB. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: component hardware for transformig growth factor-B signal transduction: TGF-B availability: latent TGF-B and latent TGF-B binding proteins. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 37-55. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; LATENCIA PROTEINA ASSOCIADA; LATENCIA ASSOCIADA PROTEINA LATENTE; PROTEINA TGF-B DE LIGACAO; MATRIZ EXTRACELULAR; PLASMINA; THROBOSPODIN-1 |
| 2/10 | US=84 / Biol/Mol Souchelnytskyi S. TGF-B superfamily members in normal and tumor biology: proteomics analysis of TGFB superfamily members. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 319-31. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. PROTEOMICA; SINALIZACAO; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; PROTEINAS MORFOGENETICAS DO OSSO; SMAD |
| 3/10 | US=84 / Biol/Mol Zhu X, Liang LF, Stotish RL. TGF-B superfamily members in normal and tumor biology: myostatin signaling in normal and tumor cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 509-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. SMAD; MIOSTATINA; FACTOR DE CRESCIMENTO TRANSFORMANTE-B; MUSCULO ESQUELETICO; VIA DE SINAL; TECIDO ADIPOSO; TUMORES RABDOMIOSSARCOMA |
| 4/10 | US=84 / Biol/Mol Cha J, Falanga V. TGF-B in inflammation and fibrosis: transforming growth factor-B in cutaneous tissue repair. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 675-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; REPARACAO DE FERIDAS; REPARACAO TECIDUAL; MATRIZ; FIBROBLASTOS; QUERATINOCITOS |
| 5/10 | US=84 / Biol/Mol Dotor J, Pablos JL. TGF-B in inflammation and fibrosis: topical application of TGF-B1 peptide inhibitors for the therapy of skin fibrosis. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 693-702. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; REPARACAO DE FERIDAS; REPARACAO TECIDUAL; MATRIZ; FIBROBLASTOS; QUERATINOCITOS |
| 6/10 | US=84-A / Biol/Mol Weber SM, Lu SL, Bernstein S, Wang XJ. Transformig growth factor-B in developing and advanced cancers: role of transforming growth factor-B in the pathogenesis of human head and neck squamous cell carcinoma. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 21-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; CARCINOMA DE CELULAS ESCAMOSAS. CABECA E PESCOCO; TRANSGENICA RATO; RATO KNOCKOUT |
| 7/10 | US=84-A / Biol/Mol Ungefroren H. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling and biglycan in pancreatic cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 51-62. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. CANCER DE PANCREAS; RECEPTOR; SMAD; BIGLICAM; PARAGEM DO CRESCIMENTO; DANO DO DNA-45B; P38 CINASE DE PROTEINA ACTIVADA POR MITOGENIO; NADPH OXIDASE; PROTEINA QUINASE C; FACTOR DE CRESCIMENTO TRANSFORMANTE-B |
| 8/10 | US=84-A / Biol/Mol Saika S. Transformig growth factor-B in developing and advanced cancers: therapeutic effects of adenovirus medated gene transfer of TGF-B signal antagonists on undesirable epithelial-mesenchymal transition and neovascularization. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 367-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TRANSICAO EPITELIAL-MESENQUIMAL; NEOVASCULARIZACAO; CICATRIZACAO DE FERIDAS; FACTOR DE CRESCIMENTO TRANSFORMANTE B; TRANSDUCAO DE SINAL; TERAPIA GENETICA |
| 9/10 | US=84-A / Biol/Mol De Crescenzo G, Chao H, Zwaagstra J, Durocher Y, O'Connor-McCourt MD. Development of inhibitors of transforming growth factor-B signaling for therapy: engineering TGB-B traps: artificially dimerized receptor ectodomains as high-affinity blockers of TGF-B action. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 671-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; ANTAGONISTA; BETAGLICAM; ARMADILHA LIGANTE; RECEPTOR ECTODOMINIO |
| 10/10 | US=84-A / Biol/Mol Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES |